| scholarly article | Q13442814 |
| P356 | DOI | 10.1158/1078-0432.CCR-07-1595 |
| P698 | PubMed publication ID | 18094407 |
| P50 | author | Craig B. Thompson | Q5180710 |
| P2093 | author name string | Ravi K Amaravadi | |
| P433 | issue | 24 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | autophagy | Q288322 |
| P304 | page(s) | 7271-7279 | |
| P577 | publication date | 2007-12-01 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Clinical Cancer Research | Q332253 |
| P1476 | title | The roles of therapy-induced autophagy and necrosis in cancer treatment | |
| P478 | volume | 13 |
| Q38785352 | 2-phenylethynesulphonamide (PFT-μ) enhances the anticancer effect of the novel hsp90 inhibitor NVP-AUY922 in melanoma, by reducing GSH levels |
| Q36642410 | 5-Benzylglycinyl-Amiloride Kills Proliferating and Nonproliferating Malignant Glioma Cells through Caspase-Independent Necroptosis Mediated by Apoptosis-Inducing Factor |
| Q36928219 | A Sensitive IHC Method for Monitoring Autophagy-Specific Markers in Human Tumor Xenografts |
| Q39284840 | A liposomal system capable of generating CO2 bubbles to induce transient cavitation, lysosomal rupturing, and cell necrosis |
| Q94470572 | A modified arginine-depleting enzyme NEI-01 inhibits growth of pancreatic cancer cells |
| Q45238832 | A new quinoxaline-containing peptide induces apoptosis in cancer cells by autophagy modulation |
| Q38116265 | A systems biology analysis of autophagy in cancer therapy |
| Q38150151 | AMP-activated protein kinase (AMPK) beyond metabolism: a novel genomic stress sensor participating in the DNA damage response pathway |
| Q46250581 | AMP-activated protein kinase (AMPK)/Ulk1-dependent autophagic pathway contributes to C6 ceramide-induced cytotoxic effects in cultured colorectal cancer HT-29 cells |
| Q89460224 | Acidic stress induces protective autophagy in SGC7901 cells |
| Q51460927 | Aggressive human neuroblastomas show a massive increase in the numbers of autophagic vacuoles and damaged mitochondria. |
| Q35931271 | Alternative approaches to eradicating the malignant clone in chronic myeloid leukemia: tyrosine-kinase inhibitor combinations and beyond |
| Q37635409 | Aluminum-phthalocyanine chloride associated to poly(methyl vinyl ether-co-maleic anhydride) nanoparticles as a new third-generation photosensitizer for anticancer photodynamic therapy |
| Q38052310 | Ambra1 at the crossroad between autophagy and cell death |
| Q92479477 | Analyses of a Panel of Transcripts Identified From a Small Sample Size and Construction of RNA Networks in Hepatocellular Carcinoma |
| Q39738527 | Anionic linear-globular dendrimer-cis-platinum (II) conjugates promote cytotoxicity in vitro against different cancer cell lines |
| Q47139059 | Anticancer Activity of Curcumin-Loaded PLGA Nanoparticles on PC3 Prostate Cancer Cells |
| Q38740544 | Anticancer activity of Kalanchoe tubiflora extract against human lung cancer cells in vitro and in vivo |
| Q64244298 | Antimicrobial Peptide TP4 Induces ROS-Mediated Necrosis by Triggering Mitochondrial Dysfunction in Wild-Type and Mutant Glioblastoma Cells |
| Q37402998 | Antioxidant Capacity, Cytotoxicity, and Acute Oral Toxicity of Gynura bicolor. |
| Q37084608 | Apogossypolone, a novel inhibitor of antiapoptotic Bcl-2 family proteins, induces autophagy of PC-3 and LNCaP prostate cancer cells in vitro |
| Q35128650 | Apoptosis, autophagy, necroptosis, and cancer metastasis |
| Q38005914 | Apoptosis-Modulating Drugs for Improved Cancer Therapy |
| Q38795585 | Apoptosis/Necrosis Induction by Ultraviolet, in ER Positive and ER Negative Breast Cancer Cell Lines. |
| Q100559255 | Application of small molecule FPR1 antagonists in the treatment of cancers |
| Q37068792 | Arginine deiminase as a novel therapy for prostate cancer induces autophagy and caspase-independent apoptosis |
| Q30402590 | Autophagy Induced by Conventional Chemotherapy Mediates Tumor Cell Sensitivity to Immunotherapy |
| Q39185200 | Autophagy Inhibition Sensitizes Colon Cancer Cells to Antiangiogenic and Cytotoxic Therapy |
| Q38701724 | Autophagy activated by the c-Jun N-terminal kinase-mediated pathway protects human prostate cancer PC3 cells from celecoxib-induced apoptosis |
| Q37967998 | Autophagy and cancer |
| Q37876679 | Autophagy as a target for anticancer therapy |
| Q27346475 | Autophagy facilitates the development of breast cancer resistance to the anti-HER2 monoclonal antibody trastuzumab |
| Q36712027 | Autophagy in acute kidney injury |
| Q26992256 | Autophagy in hepatitis C virus-host interactions: potential roles and therapeutic targets for liver-associated diseases |
| Q39426712 | Autophagy inhibition enhances ursolic acid-induced apoptosis in PC3 cells |
| Q33937865 | Autophagy inhibition enhances vorinostat-induced apoptosis via ubiquitinated protein accumulation |
| Q47106122 | Autophagy inhibition sensitizes LY3023414-induced anti-glioma cell activity in vitro and in vivo |
| Q35991524 | Autophagy inhibitor Lys05 has single-agent antitumor activity and reproduces the phenotype of a genetic autophagy deficiency |
| Q38835090 | Autophagy levels are elevated in barrett's esophagus and promote cell survival from acid and oxidative stress |
| Q37019453 | Autophagy regulates selective HMGB1 release in tumor cells that are destined to die. |
| Q39245187 | Autophagy, Senescence, and Apoptosis |
| Q38066407 | Autophagy, apoptosis, mitoptosis and necrosis: interdependence between those pathways and effects on cancer |
| Q36972773 | Autophagy-induced tumor dormancy in ovarian cancer |
| Q37472903 | Autophagy: from basic science to clinical application |
| Q47250319 | Autophagy: novel applications of nonsteroidal anti-inflammatory drugs for primary cancer. |
| Q51734667 | Avenues to molecular imaging of dying cells: Focus on cancer. |
| Q37077410 | BH3 mimetic ABT-737 sensitizes colorectal cancer cells to ixazomib through MCL-1 downregulation and autophagy inhibition |
| Q40691174 | Base excision repair pathway: PARP1 genotypes as modulators of therapy response in cervical cancer patients |
| Q44525475 | Beclin 1 activation enhances chemosensitivity and predicts a favorable outcome for primary duodenal adenocarcinoma |
| Q37420812 | Blocking autophagic flux enhances matrine-induced apoptosis in human hepatoma cells |
| Q34139732 | Cancer and inflammation: promise for biologic therapy. |
| Q34979866 | Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells |
| Q34168046 | Celecoxib-induced apoptosis is enhanced by ABT-737 and by inhibition of autophagy in human colorectal cancer cells |
| Q35069917 | Celecoxib-induced cytotoxic effect is potentiated by inhibition of autophagy in human urothelial carcinoma cells |
| Q34019760 | Cell death |
| Q37580480 | Challenges for the functional diffusion map in pediatric brain tumors |
| Q36269742 | Characterization of [(99m)Tc]Duramycin as a SPECT Imaging Agent for Early Assessment of Tumor Apoptosis |
| Q24607826 | Chloroquine activates the p53 pathway and induces apoptosis in human glioma cells |
| Q35217204 | Chloroquine enhances gefitinib cytotoxicity in gefitinib-resistant nonsmall cell lung cancer cells |
| Q50053658 | Chloroquine exerts antitumor effects on NB4 acute promyelocytic leukemia cells and functions synergistically with arsenic trioxide |
| Q41919095 | Chloroquine potentiates temozolomide cytotoxicity by inhibiting mitochondrial autophagy in glioma cells |
| Q33632727 | Chloroquine potentiates the anti-cancer effect of 5-fluorouracil on colon cancer cells |
| Q34540299 | Chrysophanol induces necrosis through the production of ROS and alteration of ATP levels in J5 human liver cancer cells |
| Q36688794 | Combination treatment with ABT-737 and chloroquine in preclinical models of small cell lung cancer |
| Q37275481 | Control of autophagy by oncogenes and tumor suppressor genes |
| Q34102626 | Crosstalk between apoptosis and autophagy: molecular mechanisms and therapeutic strategies in cancer |
| Q53431250 | Cucumarioside A2-2 stimulates apoptotic necrosis in Ehrlich ascites carcinoma cells |
| Q37745339 | Cystatin SN inhibits auranofin-induced cell death by autophagic induction and ROS regulation via glutathione reductase activity in colorectal cancer |
| Q38716060 | Cytotoxic analysis and chemical characterization of fractions of the hydroalcoholic extract of the Euterpe oleracea Mart. seed in the MCF-7 cell line. |
| Q90194241 | Cytotoxicity and Apoptosis Induction of Coumarins and Carbazole Alkaloids from Clausena harmandiana |
| Q31123725 | Development of a screen to identify selective small molecules active against patient-derived metastatic and chemoresistant breast cancer cells |
| Q37581764 | Diosmetin inhibits cell proliferation and induces apoptosis by regulating autophagy via the mammalian target of rapamycin pathway in hepatocellular carcinoma HepG2 cells |
| Q37290260 | Direct targeting of the mucin 1 oncoprotein blocks survival and tumorigenicity of human breast carcinoma cells |
| Q51415582 | Do protons and X-rays induce cell-killing in human peripheral blood lymphocytes by different mechanisms? |
| Q33881209 | Downregulation of ATG5-dependent macroautophagy by chaperone-mediated autophagy promotes breast cancer cell metastasis |
| Q36497999 | ER stress-mediated autophagy promotes Myc-dependent transformation and tumor growth |
| Q33878879 | ERBB2 overexpression suppresses stress-induced autophagy and renders ERBB2-induced mammary tumorigenesis independent of monoallelic Becn1 loss |
| Q49335119 | Effects of ginkgol C17:1 on cisplatin-induced autophagy and apoptosis in HepG2 cells |
| Q83321386 | Effects of quercetin nanoliposomes on C6 glioma cells through induction of type III programmed cell death |
| Q41142018 | Elaborating the role of natural products-induced autophagy in cancer treatment: achievements and artifacts in the state of the art. |
| Q27009194 | Emerging strategies to effectively target autophagy in cancer |
| Q91896688 | Enhancement of Quercetin-Induced Apoptosis by Cotreatment with Autophagy Inhibitor Is Associated with Augmentation of BAK-Dependent Mitochondrial Pathway in Jurkat T Cells |
| Q45976173 | Epigenetic modifiers: basic understanding and clinical development. |
| Q37763784 | Epigenetic therapy of lymphoma using histone deacetylase inhibitors |
| Q39334622 | Evaluation of the anticancer potential of six herbs against a hepatoma cell line |
| Q50086506 | FREQUENT SUBCLINICAL MACULAR CHANGES IN COMBINED BRAF/MEK INHIBITION WITH HIGH-DOSE HYDROXYCHLOROQUINE AS TREATMENT FOR ADVANCED METASTATIC BRAF MUTANT MELANOMA: Preliminary Results From a Phase I/II Clinical Treatment Trial |
| Q39777394 | Features of senescence and cell death induced by doxorubicin in A549 cells: organization and level of selected cytoskeletal proteins. |
| Q34551169 | Functional polymorphisms of FAS and FASL gene and risk of breast cancer - pilot study of 134 cases. |
| Q21134996 | Galectin-3 and Beclin1/Atg6 Genes In Human Cancers: Using cDNA Tissue Panel, qRT-PCR, and Logistic Regression Model to Identify Cancer Cell Biomarkers |
| Q28477038 | Gene expression signature analysis identifies vorinostat as a candidate therapy for gastric cancer |
| Q41416283 | Glucose Restriction Combined with Autophagy Inhibition and Chemotherapy in HCT 116 Spheroids Decreases Cell Clonogenicity and Viability Regulated by Tumor Suppressor Genes. |
| Q24608066 | Graviola: A novel promising natural-derived drug that inhibits tumorigenicity and metastasis of pancreatic cancer cells in vitro and in vivo through altering cell metabolism |
| Q34154797 | HMGB1 release and redox regulates autophagy and apoptosis in cancer cells |
| Q22252312 | Hallmarks of Cancer: The Next Generation |
| Q38227878 | Harnessing of Programmed Necrosis for Fighting against Cancers |
| Q37033622 | Heat shock protein Hsp72 controls oncogene-induced senescence pathways in cancer cells. |
| Q36395865 | Hepatitis C virus and cellular stress response: implications to molecular pathogenesis of liver diseases |
| Q47135468 | High mobility group box 1 promotes sorafenib resistance in HepG2 cells and in vivo |
| Q30401489 | High-dose chemotherapeutics of intravesical chemotherapy rapidly induce mitochondrial dysfunction in bladder cancer-derived spheroids |
| Q33623983 | Hoechst-IR: an imaging agent that detects necrotic tissue in vivo by binding extracellular DNA. |
| Q43016565 | Hsp90 inhibitor induces autophagy and apoptosis in osteosarcoma cells |
| Q24323790 | Hsp90-Cdc37 chaperone complex regulates Ulk1- and Atg13-mediated mitophagy |
| Q39762235 | Human cancer classification: a systems biology- based model integrating morphology, cancer stem cells, proteomics, and genomics |
| Q39374075 | Hypoxia-Induced Autophagy Promotes Tumor Cell Survival and Adaptation to Antiangiogenic Treatment in Glioblastoma |
| Q37299691 | IBP-mediated suppression of autophagy promotes growth and metastasis of breast cancer cells via activating mTORC2/Akt/FOXO3a signaling pathway |
| Q37577474 | Implication of transcriptional repression in compound C-induced apoptosis in cancer cells |
| Q58799521 | Inhibition of autophagy increases susceptibility of glioblastoma stem cells to temozolomide by igniting ferroptosis |
| Q36557343 | Inhibition of autophagy potentiates pemetrexed and simvastatin-induced apoptotic cell death in malignant mesothelioma and non-small cell lung cancer cells |
| Q36334074 | Inhibition of caspase-9 by oridonin, a diterpenoid isolated from Rabdosia rubescens, augments apoptosis in human laryngeal cancer cells |
| Q39532979 | Inhibition of protein degradation induces apoptosis through a microtubule-associated protein 1 light chain 3-mediated activation of caspase-8 at intracellular membranes |
| Q35006105 | JNK and macroautophagy activation by bortezomib has a pro-survival effect in primary effusion lymphoma cells. |
| Q27025213 | Killing me softly--future challenges in apoptosis research |
| Q102068375 | LOXL2 Upregulation in Gliomas Drives Tumorigenicity by Activating Autophagy to Promote TMZ Resistance and Trigger EMT |
| Q21284430 | Lectin of Concanavalin A as an anti-hepatoma therapeutic agent |
| Q39621306 | Lucanthone Is a Novel Inhibitor of Autophagy That Induces Cathepsin D-mediated Apoptosis |
| Q38930818 | Lycorine induces programmed necrosis in the multiple myeloma cell line ARH-77. |
| Q38689342 | Lysosomal Biology in Cancer |
| Q39822402 | MLH1 mediates PARP-dependent cell death in response to the methylating agent N-methyl-N-nitrosourea |
| Q37017342 | Marizomib, a proteasome inhibitor for all seasons: preclinical profile and a framework for clinical trials |
| Q41910277 | Measurements of tumor cell autophagy predict invasiveness, resistance to chemotherapy, and survival in melanoma |
| Q39138277 | Mechanistics and photo-energetics of macrocycles and photodynamic therapy: An overview of aspects to consider for research |
| Q35133254 | Meloxicam executes its antitumor effects against hepatocellular carcinoma in COX-2- dependent and -independent pathways |
| Q39582316 | Metal-Based Inhibition of Poly(ADP-ribose) Polymerase − The Guardian Angel of DNA |
| Q47644380 | Mitochondrial ROS activates ERK/autophagy pathway as a protected mechanism against deoxypodophyllotoxin-induced apoptosis |
| Q42770281 | Mode of cell death induced by the HSP90 inhibitor 17-AAG (tanespimycin) is dependent on the expression of pro-apoptotic BAX. |
| Q35100137 | Modulation of the tumor cell death pathway by androgen receptor in response to cytotoxic stimuli |
| Q38025250 | Molecular crosstalk between the proteasome, aggresomes and autophagy: Translational potential and clinical implications |
| Q100490876 | Multicompartment modeling of protein shedding kinetics during vascularized tumor growth |
| Q38119845 | Multimodal immunogenic cancer cell death as a consequence of anticancer cytotoxic treatments |
| Q24323093 | Myc sensitizes p53-deficient cancer cells to the DNA-damaging effects of the DNA methyltransferase inhibitor decitabine |
| Q28386642 | Nanomaterials and autophagy: new insights in cancer treatment |
| Q40862731 | Naringin Reverses Hepatocyte Apoptosis and Oxidative Stress Associated with HIV-1 Nucleotide Reverse Transcriptase Inhibitors-Induced Metabolic Complications |
| Q89587161 | Necrosis in the Tumor Microenvironment and Its Role in Cancer Recurrence |
| Q36796276 | Necrotic cells influence migration and invasion of glioblastoma via NF-κB/AP-1-mediated IL-8 regulation |
| Q37981834 | New frontiers in promoting tumour cell death: targeting apoptosis, necroptosis and autophagy |
| Q38789715 | New thiazacridine agents: Synthesis, physical and chemical characterization, and in vitro anticancer evaluation |
| Q41833885 | Non-apoptotic routes to defeat cancer |
| Q28822272 | Novel CHOP activator LGH00168 induces necroptosis in A549 human lung cancer cells via ROS-mediated ER stress and NF-κB inhibition |
| Q38083001 | Novel mechanism of synergistic effects of conventional chemotherapy and immune therapy of cancer |
| Q36311268 | Nucleocytoplasmic transport blockage by SV40 peptide-modified gold nanoparticles induces cellular autophagy |
| Q38730154 | Nutrient restriction of glucose or serum results in similar proteomic expression changes in 3D colon cancer cell cultures. |
| Q35846880 | Obatoclax and lapatinib interact to induce toxic autophagy through NOXA. |
| Q38081239 | Overcoming endocrine resistance in breast cancer: role of the PI3K and the mTOR pathways |
| Q37482581 | Oxyphenisatin acetate (NSC 59687) triggers a cell starvation response leading to autophagy, mitochondrial dysfunction, and autocrine TNFα-mediated apoptosis |
| Q28288793 | Pancreatic cancer cell lines deficient in argininosuccinate synthetase are sensitive to arginine deprivation by arginine deiminase |
| Q39381435 | Perpetual change: autophagy, the endothelium, and response to vascular injury |
| Q37261476 | Photoaffinity isolation and identification of proteins in cancer cell extracts that bind to platinum-modified DNA. |
| Q39922600 | Poly(ADP-ribose) polymerase-1 activity facilitates the dissociation of nuclear proteins from platinum-modified DNA. |
| Q36244099 | Potentiation of the growth inhibition activity of 2-({4-[4-(acridin-9-ylamino)phenylthio]phenyl}(2-hydroxyethyl)amino)ethan-1-ol (CK0402) by Herceptin in SKBR-3 human breast cancer cells |
| Q39622895 | Preferential cytotoxicity of bortezomib toward hypoxic tumor cells via overactivation of endoplasmic reticulum stress pathways. |
| Q34787732 | Principles and current strategies for targeting autophagy for cancer treatment |
| Q36781485 | Punctate LC3B Expression Is a Common Feature of Solid Tumors and Associated with Proliferation, Metastasis, and Poor Outcome |
| Q39959144 | Quantitation of autophagy by luciferase release assay. |
| Q33926261 | Radiosensitization of solid tumors by Z-VAD, a pan-caspase inhibitor. |
| Q64081840 | Recombinant adenoviruses expressing apoptin suppress the growth of MCF‑7 breast cancer cells and affect cell autophagy |
| Q64889587 | Redox-Related Neuronal Death and Crosstalk as Drug Targets: Focus on Epilepsy. |
| Q28541488 | Reduced Warburg effect in cancer cells undergoing autophagy: steady- state 1H-MRS and real-time hyperpolarized 13C-MRS studies |
| Q39903161 | Regulation of HMGB1 release by autophagy |
| Q38938672 | Regulatory role of autophagy in globular adiponectin-induced apoptosis in cancer cells |
| Q34978389 | SRT1720 induces lysosomal-dependent cell death of breast cancer cells |
| Q56890729 | Safety of combining radiotherapy with immune-checkpoint inhibition |
| Q30501787 | Selective anticancer activity of a hexapeptide with sequence homology to a non-kinase domain of Cyclin Dependent Kinase 4. |
| Q39646955 | Short-chain fatty acids induced autophagy serves as an adaptive strategy for retarding mitochondria-mediated apoptotic cell death |
| Q41926444 | Silencing of mitochondrial NADP+-dependent isocitrate dehydrogenase gene enhances glioma radiosensitivity |
| Q28473548 | Simultaneous induction of non-canonical autophagy and apoptosis in cancer cells by ROS-dependent ERK and JNK activation |
| Q34660074 | Small‐Molecule Regulators of Autophagy and Their Potential Therapeutic Applications |
| Q37701644 | Subcellular localization of FOXO3a as a potential biomarker of response to combined treatment with inhibitors of PI3K and autophagy in PIK3CA-mutant cancer cells |
| Q35011149 | Synergistic Interactions between Heregulin and Peroxisome Proliferator-activated Receptor-γ (PPARγ) Agonist in Breast Cancer Cells |
| Q35751958 | Synergistic antitumor activity of camptothecin-doxorubicin combinations and their conjugates with hyaluronic acid. |
| Q38776554 | Tanshinone I induces apoptosis and pro-survival autophagy in gastric cancers |
| Q40660312 | Targeted deletion of autophagy-related 5 (atg5) impairs adipogenesis in a cellular model and in mice |
| Q39598975 | Targeting Autophagy Augments In Vitro and In Vivo Antimyeloma Activity of DNA-Damaging Chemotherapy |
| Q39020884 | Targeting ER stress-induced autophagy overcomes BRAF inhibitor resistance in melanoma. |
| Q39528565 | Targeting FcαRI on Polymorphonuclear Cells Induces Tumor Cell Killing through Autophagy |
| Q28066270 | Targeting autophagy to sensitive glioma to temozolomide treatment |
| Q47257003 | Targeting urothelial carcinoma cells by combining cisplatin with a specific inhibitor of the autophagy-inducing class III PtdIns3K complex. |
| Q35684572 | The CCL2 chemokine is a negative regulator of autophagy and necrosis in luminal B breast cancer cells |
| Q37136752 | The Isopeptidase Inhibitor G5 Triggers a Caspase-independent Necrotic Death in Cells Resistant to Apoptosis: A COMPARATIVE STUDY WITH THE PROTEASOME INHIBITOR BORTEZOMIB |
| Q60031638 | The Multifaceted Roles of Autophagy in Flavivirus-Host Interactions |
| Q49178791 | The Role of Ferroptosis in Cancer Development and Treatment Response |
| Q37580269 | The anti-cancer activity of the mTORC1/2 dual inhibitor XL388 in preclinical osteosarcoma models |
| Q38092648 | The antibody-drug conjugate: an enabling modality for natural product-based cancer therapeutics |
| Q39010852 | The combination of rapamycin and MAPK inhibitors enhances the growth inhibitory effect on Nara-H cells |
| Q37331327 | The double-edged sword of autophagy modulation in cancer |
| Q36087855 | The histone deacetylase inhibitors LAQ824 and LBH589 do not require death receptor signaling or a functional apoptosome to mediate tumor cell death or therapeutic efficacy |
| Q38782471 | The impact of autophagy on cell death modalities in CRL-5876 lung adenocarcinoma cells after their exposure to γ-rays and/or erlotinib |
| Q89395265 | The independence of and associations among apoptosis, autophagy, and necrosis |
| Q37642093 | The role of autophagy in tumour development and cancer therapy. |
| Q39474193 | The time-dependent autophagy protects against apoptosis with possible involvement of Sirt1 protein in multiple myeloma under nutrient depletion |
| Q47160527 | Theranostic Role of 32P-ATP as Radiopharmaceutical for the Induction of Massive Cell Death within Avascular Tumor Core |
| Q55233805 | Therapeutic potential of Bcl-xL/Mcl-1 synthetic inhibitor JY-1-106 and retinoids for human triple-negative breast cancer treatment. |
| Q39944174 | Therapeutic starvation and autophagy in prostate cancer: a new paradigm for targeting metabolism in cancer therapy |
| Q84111047 | Toll‐like receptor 7 agonist, Imiquimod, inhibits oral squamous carcinoma cells through apoptosis and necrosis |
| Q27024127 | Tumor Cell Autophagy as an Adaptive Response Mediating Resistance to Treatments Such as Antiangiogenic Therapy |
| Q33779645 | Ulk1 over-expression in human gastric cancer is correlated with patients' T classification and cancer relapse |
| Q64902286 | Unappreciated Role of LDHA and LDHB to Control Apoptosis and Autophagy in Tumor Cells. |
| Q90327160 | Yeast β-D-glucan exerts antitumour activity in liver cancer through impairing autophagy and lysosomal function, promoting reactive oxygen species production and apoptosis |
| Q39044806 | Zinc status alters growth and oxidative stress responses in rat hepatoma cells |
| Q28078490 | mTOR: An attractive therapeutic target for osteosarcoma? |
Search more.